NovAb, Inc.
PrivateLast Round
Debt
Apr 16, 2026
Total Funding Raised
$893,664
Company Overview
NovAb, Inc. is a biotechnology company that develops monoclonal antibodies for therapeutic and diagnostic applications.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NovAb, Inc. Comps
Public and private peers based on sector, stage, and business model.
NovAb, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 16, 2026 | ||||
| Early Funding | Jan 26, 2026 | ||||
| Grant | Sep 19, 2023 | ||||
| Grant | Aug 1, 2021 | ||||
| Grant | Sep 10, 2014 |
NovAb, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant, Debt |
| National Institute of Allergy and Infectious Diseases | Debt, Grant |
| NIH RADx | Grant |
| National Institute of General Medical Sciences | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
$65K debt round completed.
- Jan 26, 2026
$50K raised in early funding.
NovAb, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NovAb, Inc.'s valuation, stock price, and market status.
